IQV — IQVIA Holdings Inc.
$279.36+0.37%
Last close: · regular session
Last 60 sessions
IQV closed at $279.36 (+0.37%) on Oct 23, 2026. Float: 149.6M shares. Latest SEC filing: 8-K on Jun 11, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for IQV in the TickerWise workspace.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Company profile
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: US
- Exchange: NYSE
- Employees: 89,000
- Website: https://www.iqvia.com
Latest SEC filings for IQV
Latest IQV news
- IQVIA Q3 2026 Earnings Preview Read article
- IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? Read article
- VEEV Expands IQVIA Partnership With Clinical Operations Software Suite Read article
- IQVIA opte pour les applications de Veeva Clinical Operations Read article
- IQVIA selecciona las aplicaciones de Veeva Clinical Operations Read article
- IQVIA entscheidet sich für Veeva-Anwendungen für klinische Abläufe Read article
- IQVIA Selects Veeva Clinical Operations Applications Read article
- Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.